Respiratory Medicine

Innovative research focusing on non-small cell lung cancer (NSCLC) treatments, evaluating novel combination therapies and comparing their effectiveness to standard treatments.

  • Advanced NSCLC Treatment Studies
  • Immunotherapy Combinations
  • COPD Management Research

Studies include investigations of triple therapy approaches for chronic obstructive pulmonary disease patients, aiming to reduce exacerbation rates.

Oncology Research

Groundbreaking trials examining new therapeutic approaches for lung cancer, particularly focusing on immunotherapy combinations and targeted treatments.

  • PD-L1 Expression Studies
  • Novel Drug Combinations
  • Treatment Resistance Solutions

Research emphasizes personalized treatment approaches based on specific biomarkers and patient characteristics.

Cardiovascular Medicine

Essential clinical research addressing atrial fibrillation and acute coronary syndrome, testing innovative therapeutic agents for better patient outcomes.

  • Stroke Prevention Studies
  • Post-Heart Attack Care
  • Cardiovascular Event Prevention

Trials focus on reducing recurrent cardiovascular events and improving long-term patient prognosis.